Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
9
2024
Oregon Prescription Drug Price Transparency Act in Limbo Sheppard, Mullin, Richter & Hampton LLP
Mar
8
2024
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US Keller and Heckman LLP
Mar
8
2024
BioMarin Subpoena Potentially Signals Continued Investigations into Sponsored Testing Programs Epstein Becker & Green, P.C.
Mar
8
2024
UK Spring Budget 2024 Cadwalader, Wickersham & Taft LLP
Mar
8
2024
Georgia Laboratory Owner Pleads Guilty to Felony Anti-Kickback Statute Violations ArentFox Schiff LLP
Mar
7
2024
Health Law Diagnosed – A Discussion on the Regulatory Requirements for LDTs [Podcast] Mintz
Mar
7
2024
Making Moves – FDA’s LDT Proposed Rule Sent to OMB for Review Epstein Becker & Green, P.C.
Mar
7
2024
China on the Move: Lessons from China’s 2023 National Negotiation of Drug Prices Greenberg Traurig, LLP
Mar
6
2024
ACA-Required Coverage of Contraceptive Care Remains Agency Focus Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Mar
6
2024
Implementation of Strengthening Organic Enforcement Rule Begins this Month Keller and Heckman LLP
Mar
6
2024
FDA Faces Critical Deadlines in 2024, Even Without an Election Looming Mintz
Mar
6
2024
Medical Marijuana Usage Is Not Protected Under the ADA, Vermont Federal Court Rules Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Mar
5
2024
Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast [Podcast] K&L Gates
Mar
5
2024
Cannabis Legalization Efforts: How Far Did They Reach in 2023? How High Can They Go in an Election Year? Womble Bond Dickinson (US) LLP
Mar
5
2024
DOE Intends to Issue Funding to Support Mixed Algae and Wet Waste Feedstocks R&D for Biofuels and Bioproducts Bergeson & Campbell, P.C.
Mar
5
2024
Unpacking Averages: Analyzing FDA’s Performance in Finalizing Guidance Documents Epstein Becker & Green, P.C.
Mar
5
2024
SAMHSA Final Rule Regarding OTPs Expands Access, Increases Flexibility for Patients Epstein Becker & Green, P.C.
Mar
5
2024
CA Federal Court Awards Biomedical Companies $62M Following Jury Trial Involving Confidentiality-Related Claims Proskauer Rose LLP
Mar
5
2024
FDA Updates List of Chemicals Under Review Keller and Heckman LLP
Mar
4
2024
FDA Issues Update on Post-Market Assessments of Chemicals in the Food Supply Bergeson & Campbell, P.C.
Mar
4
2024
From the Year of the Rabbit to the Year of the Dragon: China’s Food Law Year-in-Review 2023 Keller and Heckman LLP
Mar
4
2024
USDA Seeks Comments on Petition to Deregulate Corn Developed Using Genetic Engineering Bergeson & Campbell, P.C.
Mar
4
2024
New York Attorney General Sues JBS for its Climate Claims Womble Bond Dickinson (US) LLP
Mar
4
2024
Navigating Hemp THC Beverages McDermott Will & Emery
Mar
4
2024
Alabama Supreme Court Rules Negligent Destruction of IVF Embryos May Be Treated as Wrongful Death Greenberg Traurig, LLP
Mar
1
2024
CODEX ALIMENTARIUS: Outcome of 7th Codex Committee – Spices and Culinary Herbs (CCSCH7) Keller and Heckman LLP
Mar
1
2024
European Industries Call for “Bold and Impactful” Biotechnology and Biomanufacturing Initiative Bergeson & Campbell, P.C.
Mar
1
2024
FDA Proposes Rule to Update Clinical Trial Data Monitoring McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins